Cerebrovascular carbon dioxide reactivity in children anaesthetized with propofol

Area of Science:

• Pediatric Anesthesiology
• Neuroanesthesia
• Cerebrovascular Physiology

Background:

• Propofol is increasingly used for pediatric anesthesia due to its favorable pharmacokinetics.
• Its effects on cerebrovascular CO2 reactivity in children require further investigation.
• Understanding this is crucial for safe neurosurgical procedures in pediatric patients.

Purpose of the Study:

• To evaluate the impact of propofol anesthesia on carbon dioxide cerebrovascular reactivity in children.
• To assess how changes in end-tidal CO2 affect middle cerebral artery blood flow velocity during propofol infusion in pediatric patients.

Main Methods:

• Ten healthy children (1-6 years) undergoing elective urological surgery received propofol anesthesia and caudal epidural block.
• End-tidal CO2 (PECO2) was manipulated between 3.3, 5.2, and 7.2 kPa (25-55 mmHg) using an exogenous CO2 source.
• Middle cerebral artery blood flow velocity was measured using transcranial Doppler sonography.

Main Results:

• Cerebral blood flow velocity significantly increased as PECO2 rose from 3.3 to 5.2 kPa and from 5.2 to 7.2 kPa (P < 0.001 for both).
• No significant changes were observed in mean heart rate or blood pressure.
• This demonstrates preserved cerebrovascular CO2 responsiveness.

Conclusions:

• Cerebrovascular CO2 reactivity is maintained in healthy children anesthetized with propofol across a range of PECO2 values (3.3-7.2 kPa).
• Propofol anesthesia does not appear to impair the brain's ability to regulate blood flow in response to CO2 changes in this age group.